Study investigated the risk of cardiovascular side effects following treatment with doxorubicin in patients with DLBCL.
Home / Resource Library / Doxorubicin and subsequent risk of cardiovascular diseases among survivors of diffuse large B-cell lymphoma in Hong Kong